Back to results
CompletedPhase 2

Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients

NCT06836063

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Woodland International Research Group LLC

Little Rock, Arkansas, United States

+34 additional locations

View on ClinicalTrials.gov
Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients — TrialFind